Rebecca A. Wright

Altered proliferation and networks in neural cells derived from idiopathic autistic individuals

Maria C. Marchetto, Haim Belinson, Yuan Tian et al. · Molecular Psychiatry · 2016 · 503 citations · Full text

Medicine, Neurobiology, Neuroscience +14

Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740):  A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties

James A. Monn, Matthew J. Valli, Steven M. Massey et al. · Journal of Medicinal Chemistry · 1997 · 393 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

Anne Kingston, Paul L. Ornstein, Rebecca A. Wright et al. · Neuropharmacology · 1998 · 365 citations

Life Sciences, Neuroscience, Pharmacology +16

Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs

Amy L. Firth, Tushar Menon, Gregory S. Parker et al. · Cell Reports · 2015 · 325 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740):  Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors

James A. Monn, Matthew J. Valli, Steven M. Massey et al. · Journal of Medicinal Chemistry · 1999 · 288 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17